Psychiatric Medications Treatment - Chart of Psychiatric Medications for Children

Bookmark and Share

CHILDREN'S PSYCHIATRIC MEDICATION CHART

TRADE NAMEGENERIC NAMEAPPROVED AGE
Stimulant Medications
Adderallamphetamine3 and older
Adderall XRamphetamine
(extended release)
6 and older
Concertamethylphenidate
(long acting)
6 and older
Dexedrinedextroamphetamine3 and older
Dextrostatdextroamphetamine3 and older
Focalindexmethylphenidate6 and older
Metadate ERmethylphenidate
(extended release)
6 and older
Ritalinmethylphenidate6 and older
Non-stimulant for ADHD
Stratteraatomoxetine6 and older
Antidepressant and Antianxiety Medications
Anafranilclomipramine10 and older (for OCD)
BuSparbuspirone18 and older
Effexorvenlafaxine18 and older
Luvox (SSRI)fluvoxamine8 and older (for OCD)
Paxil (SSRI)paroxetine18 and older
Prozac (SSRI)fluoxetine18 and older
Serzone (SSRI)nefazodone18 and older
Sinequandoxepin12 and older
Tofranilimipramine6 and older (for bedwetting)
Wellbutrinbupropion18 and older
Zoloft (SSRI)sertraline6 and older (for OCD)
Antipsychotic Medications
Clozaril (atypical)clozapine18 and older
Haldolhaloperidol3 and older
Risperdal (atypical)risperidone18 and older
Seroquel (atypical)quetiapine18 and older
Mellarilthioridazine2 and older
Zyprexa (atypical)olanzapine18 and older
Orappimozide12 and older
(for Tourette's syndrome-Data
for age 2 and older indicate
similar safety profile)
Mood Stabilizing Medications
Cibalith-Slithium citrate12 and older
Depakotevalproic acid2 and older (for seizures)
Eskalithlithium carbonate12 and older
Lithobidlithium carbonate12 and older
Tegretolcarbamazepineany age (for seizures)

REFERENCES

advertisement

1Fenton WS. Prevalence of spontaneous dyskinesia in schizophrenia. Journal of Clinical Psychiatry, 2000; 62 (suppl 4): 10-14.

2Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. For the Divalproex Maintenance Study Group. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Archives of General Psychiatry, 2000; 57(5): 481-489.

3Vainionp J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology, 1999; 45(4): 444-450.

4Soames JC. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries. Bipolar Disorder, 2000; 2(1): 37-41.

5Thase ME, and Sachs GS. Bipolar depression: Pharmacotherapy and related therapeutic strategies. Biological Psychiatry, 2000; 48(6): 558-572.

6Department of Health and Human Services. 1999. Mental Health: A Report of the Surgeon General. Rockville, MD: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institute of Mental Health.

7Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, and Mintz J. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines. American Journal of Psychiatry, 1996; 153(5): 592-606.

8Physicians' Desk Reference, 54th edition. Montavale, NJ: Medical Economics Data Production Co. 2000.

continue: Addendum